Raymond James Financial Inc. Makes New Investment in Akebia Therapeutics, Inc. (NASDAQ:AKBA)
Raymond James Financial Inc. bought a new position in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 44,748 shares of the biopharmaceutical company’s stock, valued at approximately $85,000. A number of other […]
Raymond James Financial Inc. bought a new position in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 44,748 shares of the biopharmaceutical company’s stock, valued at approximately $85,000. A number of other […]
